NCT07318805 A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors Status RECRUITING Phase PHASE1
NCT07318389 ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer Status NOT_YET_RECRUITING Phase EARLY_PHASE1
NCT07300150 A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT07286149 A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F) Status RECRUITING Phase PHASE1/PHASE2
NCT07252739 KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J) Status RECRUITING Phase PHASE2
NCT07247110 A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001) Status RECRUITING Phase PHASE1
NCT07223047 A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies Status RECRUITING Phase PHASE1/PHASE2
NCT07216105 FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT07209111 A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014) Status RECRUITING Phase PHASE2
NCT07063212 A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC) Status RECRUITING Phase PHASE2
NCT07059221 A Trial of SHR-A2102 With Adebrelimab With or Without Other Anti-tumor Therapies in Recurrent/MetastaticHead and Neck Squamous Cell Carcinoma Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT07042295 Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune System Status RECRUITING Phase PHASE2
NCT07020221 A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06997497 A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012) Status RECRUITING Phase PHASE3
NCT06943820 AK129 Combination Therapy for Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06935188 Dalpicilib Plus Cetuximab Compared With Cetuximab Alone in HPV-negative, Anti-PD-1-resistant R/M HNSCC Status RECRUITING Phase PHASE2
NCT06928584 Hypofractionated Radiotherapy Plus Immunotherapy Versus Conventional Radiotherapy in Locally Recurrent Rectal Cancer Status RECRUITING Phase PHASE2
NCT06912087 Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC Status RECRUITING Phase PHASE1